Trial: 201911180

A PHASE 1 STUDY TO EVALUATE THE SAFETY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF ESCALATING DOSES OF PF-06940434 IN PATIENTS WITH ADVANCED OR METASTATIC SOLID TUMORS

Phase

I

Principal Investigator

Adkins, Douglas

Disease Site

Corpus Uteri; Esophagus; Ill-Defined Sites; Kidney; Lip, Oral Cavity and Pharynx; Liver; Lung; Lung Cancer – Non-small Cell; Lung Cancer – Small Cell; Melanoma, Skin; Ovary; Pancreas; Stomach; Urinary Bladder

Learn more about this study at: clinicaltrials.gov